학술논문

Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer’s disease
Document Type
article
Source
Nature Communications. 8(1)
Subject
Biochemistry and Cell Biology
Biological Sciences
Alzheimer's Disease
Brain Disorders
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Acquired Cognitive Impairment
Neurosciences
Neurodegenerative
Aging
Dementia
2.1 Biological and endogenous factors
Aetiology
Neurological
Alzheimer Disease
Amyloid beta-Protein Precursor
Animals
Astrocytes
Brain
Connective Tissue Growth Factor
Disease Models
Animal
Hippocampus
Humans
Male
Mice
Mice
Inbred C57BL
Mice
Nude
Mice
Transgenic
Peptide Library
Peptides
Cyclic
Protein Binding
Language
Abstract
Cerebrovascular changes occur in Alzheimer's disease (AD). Using in vivo phage display, we searched for molecular markers of the neurovascular unit, including endothelial cells and astrocytes, in mouse models of AD. We identified a cyclic peptide, CDAGRKQKC (DAG), that accumulates in the hippocampus of hAPP-J20 mice at different ages. Intravenously injected DAG peptide homes to neurovascular unit endothelial cells and to reactive astrocytes in mouse models of AD. We identified connective tissue growth factor (CTGF), a matricellular protein that is highly expressed in the brain of individuals with AD and in mouse models, as the target of the DAG peptide. We also showed that exogenously delivered DAG homes to the brain in mouse models of glioblastoma, traumatic brain injury, and Parkinson's disease. DAG may potentially be used as a tool to enhance delivery of therapeutics and imaging agents to sites of vascular changes and astrogliosis in diseases associated with neuroinflammation.